Replies to post #121328 on Biotech Values

[north40000]

Presumably, damages remain, if AMLN chooses to pursue the issue.
Their PR seems to indicate it will.

I am hoping its metreleptin trials prove fruitful soon, as current results[favorable] indicate earlier.